Amyloidosis is an assemblage of clinically diverse disorders, either systemic or localized, resulting in abnormal protein accumulation and deposition in the heart, liver, kidneys, gastrointestinal tract, and/or soft tissues. Despite increased awareness in recent years, diagnosis and management continues to be a challenge. With a median survival rate of less than one year without treatment, accurate and timely recognition has been shown to lead to a better prognosis, increased treatment options, and long-term survival. A Guide for the Diagnosis and Management of Amyloidosis offers clinicians a comprehensive and multidisciplinary approach to effectively recognize, workup, and treat amyloid disease.  

Content includes:
- Assessment of amyloidosis red flag symptoms, history, diagnostic testing and physical findings
- Pharmacologic treatment, device therapy and advance therapy options
- Discussion of multisystem involvement and recommendations to improve patient outcomes
- End of life and palliative care throughout the disease trajectory to improve quality of life
- Required infrastructure for the creation of Amyloidosis clinics and non-branded patient educational tools

Each chapter includes a clinical pearl table with take-away concepts, applicable in clinical practice. A Guide for the Diagnosis and Management of Amyloidosis aims to help health care providers become proficient in recognizing and treating this once lethal, now treatable disease.